UBS Group’s The Oncology Institute, Inc. Warrant TOIIW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $187 | Buy |
3,670
+649
| +21% | +$33 | ﹤0.01% | 8610 |
|
|
2025
Q1 | $82 | Sell |
3,021
-85
| -3% | -$2 | ﹤0.01% | 8648 |
|
|
2024
Q4 | $16 | Sell |
3,106
-2,977
| -49% | -$15 | ﹤0.01% | 8540 |
|
|
2024
Q3 | $122 | Sell |
6,083
-2,706
| -31% | -$54 | ﹤0.01% | 7920 |
|
|
2024
Q2 | $229 | Buy |
+8,789
| New | +$229 | ﹤0.01% | 7893 |
|
|
2023
Q4 | – | Sell |
-1,034
| Closed | -$88 | – | 8555 |
|
|
2023
Q3 | $88 | Buy |
+1,034
| New | +$88 | ﹤0.01% | 7768 |
|
|
2023
Q1 | – | Sell |
-610
| Closed | -$67 | – | 9021 |
|
|
2022
Q4 | $67 | Sell |
610
-4,889
| -89% | -$537 | ﹤0.01% | 9246 |
|
|
2022
Q3 | $3K | Buy |
5,499
+25
| +0.5% | +$14 | ﹤0.01% | 8479 |
|
|
2022
Q2 | $3K | Buy |
5,474
+1,000
| +22% | +$548 | ﹤0.01% | 8323 |
|
|
2022
Q1 | $5K | Buy |
4,474
+102
| +2% | +$114 | ﹤0.01% | 8112 |
|
|
2021
Q4 | $3K | Buy |
+4,372
| New | +$3K | ﹤0.01% | 8568 |
|